Display options
Cite
Borelli MI, Gagliardino JJ. Possible modulatory effect of endogenous islet catecholamines on insulin secretion. BMC Endocr Disord. 2001;1(1):1doi: 10.1186/1472-6823-1-1.
Borelli, M. I., & Gagliardino, J. J. (2001). Possible modulatory effect of endogenous islet catecholamines on insulin secretion. BMC endocrine disorders, 1(1), 1. https://doi.org/10.1186/1472-6823-1-1
Borelli, Maria I, and Gagliardino, Juan J. "Possible modulatory effect of endogenous islet catecholamines on insulin secretion." BMC endocrine disorders vol. 1,1 (2001): 1. doi: https://doi.org/10.1186/1472-6823-1-1
Borelli MI, Gagliardino JJ. Possible modulatory effect of endogenous islet catecholamines on insulin secretion. BMC Endocr Disord. 2001;1(1):1. doi: 10.1186/1472-6823-1-1. PMID: 11696250; PMCID: PMC59668.
Copy Download .nbib Format: NLM
Share it on

BMC Endocr Disord. 2001;1(1):1. doi: 10.1186/1472-6823-1-1.

Possible modulatory effect of endogenous islet catecholamines on insulin secretion.

BMC endocrine disorders

Maria I Borelli, Juan J Gagliardino

Affiliations

  1. CENEXA - Center of Experimental and Applied Endocrinology (National University of La Plata-National Research Council, PAHO/WHO Collaborating Center), School of Medical Sciences, 60 y 120, 1900 La Plata, Argentina. [email protected]

PMID: 11696250 PMCID: PMC59668 DOI: 10.1186/1472-6823-1-1

Abstract

BACKGROUND: The possible participation of endogenous islet catecholamines (CAs) in the control of insulin secretion was tested. METHODS: Glucose-induced insulin secretion was measured in the presence of 3-Iodo-L-Tyrosine (MIT), a specific inhibitor of tyrosine-hydroxylase activity, in fresh and precultured islets isolated from normal rats. Incubated islets were also used to measure CAs release in the presence of low and high glucose, and the effect of alpha2-(yohimbine [Y] and idazoxan [I]) and alpha1-adrenergic antagonists (prazosin [P] and terazosin [T]) upon insulin secretion elicited by high glucose. RESULTS: Fresh islets incubated with 16.7 mM glucose released significantly more insulin in the presence of 1 &mgr;M MIT (6.66 +/- 0.39 vs 5.01 +/- 0.43 ng/islet/h, p < 0.02), but did not affect significantly the insulin response to low glucose. A similar enhancing effect of MIT upon insulin secretion was obtained using precultured islets devoid of neural cells, but absolute values were lower than those from fresh islets, suggesting that MIT inhibits islet rather than neural tyrosine hydroxylase. CAs concentration in the incubation media of fresh isolated islets was significantly higher in the presence of 16.7 than 3.3 mM glucose: dopamine 1.67 +/- 0.13 vs 0.69 +/- 0.13 pg/islet/h, p < 0.001, and noradrenaline 1.25 +/- 0.17 vs 0.49 +/- 0.04 pg/islet/h, p < 0.02. Y and I enhanced the release of insulin elicited by 16.7 mM glucose while P and T decreased such secretion. CONCLUSION: Our results suggest that islet-originated CAs directly modulate insulin release in a paracrine manner.

References

  1. Aust J Biol Sci. 1983;36(5-6):519-23 - PubMed
  2. Pancreas. 1989;4(6):662-7 - PubMed
  3. Eur J Pharmacol. 1981 Apr 24;71(1):93-104 - PubMed
  4. J Clin Endocrinol Metab. 1965 Oct;25(10 ):1375-84 - PubMed
  5. Clin Chem. 1986 Nov;32(11):2030-3 - PubMed
  6. Acta Endocrinol (Copenh). 1981 Apr;96(4):498-504 - PubMed
  7. Cell Tissue Res. 1987 Nov;250(2):435-9 - PubMed
  8. Neuroendocrinology. 1993 Mar;57(3):476-80 - PubMed
  9. Neuroscience. 1995 Aug;67(4):967-76 - PubMed
  10. Diabetes Res. 1989 Jun;11(2):81-4 - PubMed
  11. Diabetes Metab. 1997 Apr;23(2):161-3 - PubMed
  12. Acta Endocrinol (Copenh). 1964 Jan;45:133-8 - PubMed
  13. Diabetes. 1967 Jan;16(1):35-9 - PubMed
  14. Diabetologia. 1986 Dec;29(12):827-36 - PubMed
  15. Science. 1986 May 16;232(4752):875-7 - PubMed
  16. J Endocrinol. 1996 Mar;148(3):531-43 - PubMed
  17. Acta Endocrinol (Copenh). 1984 Jan;105(1):78-82 - PubMed
  18. Endocrinology. 1985 Sep;117(3):824-33 - PubMed
  19. Pancreas. 1986;1(5):415-20 - PubMed
  20. Development. 1993 Aug;118(4):1031-9 - PubMed
  21. Diabetologia. 2000 Apr;43(4):393-410 - PubMed
  22. Br J Pharmacol. 1991 Jul;103(3):1824-8 - PubMed
  23. Histochemistry. 1994 Jun;101(5):313-23 - PubMed
  24. Physiol Rev. 1974 Jul;54(3):596-619 - PubMed
  25. Cell Signal. 1997 Jan;9(1):71-8 - PubMed
  26. J Pharmacol Exp Ther. 1981 Mar;216(3):607-12 - PubMed
  27. Diabetologia. 1974 Oct;10(5):411-4 - PubMed
  28. J Pharmacol Exp Ther. 1965 Apr;148:1-8 - PubMed

Publication Types